CD80 Antikörper
Kurzübersicht für CD80 Antikörper (ABIN135272)
Target
Alle CD80 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Mouse CD80, Mr 52-55 kDa
-
Produktmerkmale
- Rat Anti-Mouse CD80-LE/AF
-
Aufreinigung
- Ion exchange
-
Endotoxin-Niveau
- Low endotoxin
-
Immunogen
- Activated 5C2 cells
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
-
- Applications: FC - Quality tested , IP - Reported in literature , Block - Reported in literature
- Working Dilutions: Flow Cytometry FITC and BIOT conjugates 1 g/106 cells PE, APC, and SPRD conjugates 0.2 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
-
Kommentare
-
In vivo and in vitro blocking of ligand binding
-
Probenmenge
- 1 mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- 0.5 mg of purified immunoglobulin in 1.0 mL of PBS
-
Konservierungsmittel
- Azide free
-
Handhabung
- Each reagent is stable for the period shown on the bottle label if stored as directed.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and freeze the low endotoxin, azide-free product at -20 °C immediately upon receipt.
-
-
- CD80
-
Andere Bezeichnung
- CD80
-
Hintergrund
- CD80 (B7-1) is a type I transmembrane glycoprotein and a member of the immunoglobulin superfamily of cell surface receptors. It is constitutively expressed by dendritic cells, monocytes, and peritoneal macrophages. Expression of CD80 on B cells is upregulated after activation by various means including stimulation by LPS, IL-4, and surface Ig receptor cross linking with peak expression occurring between 48 and 72 hours post-activation. The interaction of CD80/B7-1 with its ligands, CD28 and CD152/CTLA-4, provides a potent costimulatory signal for T cells activated through the CD3/T cell receptor complex.
-
Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-